NASDAQ:RLYP - Relypsa Stock Price, News, & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
eye icon Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume2.93 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Relypsa, Inc is a United States-based biopharmaceutical company. The Company focuses on the discovery, development and commercialization of polymer-based medicines. The Company's technology platform includes a high-throughput chemistry process, enabling the Company to explore various potential polymer medicines for each disease it seeks to address. Its polymers are non-absorbed, meaning they act within the gastrointestinal tract and do not get absorbed into the bloodstream or other parts of the body. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:RLYP
CUSIPN/A
Phone+1-650-4219500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive RLYP News and Ratings via Email

Sign-up to receive the latest news and ratings for RLYP and its competitors with MarketBeat's FREE daily newsletter.

Relypsa (NASDAQ:RLYP) Frequently Asked Questions

What is Relypsa's stock symbol?

Relypsa trades on the NASDAQ under the ticker symbol "RLYP."

Has Relypsa been receiving favorable news coverage?

News stories about RLYP stock have trended extremely negative on Tuesday, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Relypsa earned a coverage optimism score of -4.0 on InfoTrie's scale. They also gave headlines about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Relypsa.

What other stocks do shareholders of Relypsa own?

What is Relypsa's official website?

The official website for Relypsa is http://www.relypsa.com/.

How can I contact Relypsa?

Relypsa's mailing address is 100 Cardinal Way, REDWOOD CITY, CA 94063-4755, United States. The biotechnology company can be reached via phone at +1-650-4219500.


MarketBeat Community Rating for Relypsa (NASDAQ RLYP)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  423 (Vote Outperform)
Underperform Votes:  230 (Vote Underperform)
Total Votes:  653
MarketBeat's community ratings are surveys of what our community members think about Relypsa and other stocks. Vote "Outperform" if you believe RLYP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RLYP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/25/2019 by MarketBeat.com Staff

Featured Article: Put Option

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel